Biological determinants of cognitive change in normal aging and dementia

References

• Arai H., Lee V. M.-Y., Otvos L., Jr, Greenberg D.V., Lowery D.E., Sharma S.K., Schmidt M.L., Trojanowski J.Q. Defined neurofilament, τ and β-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proceedings of the National Academy of Sciences, USA 1990; 87: 2249–2253
   PubMedGoogle Scholar
• Ball M.J. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with aging and dementia. A quantitative study. Acta Neuropathologica (Berl) 1977; 37: 111–118
   PubMed Web of Science ®Google Scholar
• Bancher C., Jellinger K.A. Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: A rare subtype in very old subjects. Acta Neuropathologica (Berl) 1994; 88: 565–570
   Google Scholar
• Basun H., Grut M., Winblad B., Lannfelt L. Apolipoprotein ε4 allele and disease progression in patients with late-onset Alzheimer's disease. Neuroscience Letters 1995; 183: 32–34
   PubMed Web of Science ®Google Scholar
• Bennett D.A., Cochran E.J., Saper C.B., Leverenz J.B., Gilley D.W., Wilson R.S. Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease. Neurobiology of Aging 1993; 14: 589–596
   Google Scholar
• Bierer L.M., Hof P.R., Purohit D.P., Carlin L., Schmeidler J., Davis K.L., Perl D.P. Neocortical neurofibrillary tangles correlated with dementia severity in Alzheimer's disease. Archives of Neurology 1995; 52: 81–88
   PubMedGoogle Scholar
• Bouras C., Hof P.R., Morrison J.H. Neurofibrillary tangle densities in the hippocampal formation in non-demented population define subgroups of patients with differential early pathologic changes. Neuroscience Letters 1993; 153: 131–135
   Google Scholar
• Bondareff W., Mountjoy C.Q., Wischik C.M., Hauser D.L., LaBree L.D., Roth M. Evidence of subtypes of Alzheimer's disease and implications for etiology. Archives of General Psychiatry 1993; 50: 350–356
   PubMedGoogle Scholar
• Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica (Berl) 1991; 81: 161–168
   Google Scholar
• Braak H., Duyckaerts C., Braak E., Piette F. Neuropathological staging of Alzheimer-related changes correlates with psychometrically assessed intellectual status. Alzheimer's disease: Advances in Clinical and Basic Research, B. Corain, K. Iqbal, M. Nicolini, B Winblad, H. Wisniewski, P. Zatta. John Wiley, & Sons Ltd, New York 1993; 131–137
   Google Scholar
• Brun A., Gustafson L., Samuelsson S.M., Ericsson C. Neuropathology of late life. Dementia 1992; 3: 125–130
   Google Scholar
• Brun A., Liu X., Erikson C. Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration. Neurodegeneration 1995; 4: 171–177
   PubMedGoogle Scholar
• Chen M.S., Obar R.A., Schroeder C.C., Austin T.W., Poodry C.A., Wadsworth S.C., Vallee R.B. Multiple forms of dynamin are encoded by shibire, a Drosophila gene involved in endocytosis. Nature 1991; 351: 583–586
   PubMed Web of Science ®Google Scholar
• Chong J.K., Miller B.E., Ghanbari H.A. Detection of beta amyloid precursor immunoreactivity in normal and Alzheimer's disease cerebrospinal fluid. Life Sciences 1990; 47: 1163–1171
   Google Scholar
• Cleary J., Hittner J.M., Semotuk M., Mantyh P., O'Hare E. Beta amyloid (1–40) effects on behavior and memory. Brain Research 1995; 682: 69–74
   PubMed Web of Science ®Google Scholar
• Clinton J., Forsyth C., Royston M.C., Roberts G.W. Synaptic degeneration is die primary neuropathological feature in prion disease: A preliminary study. Neuro Report 1993; 4: 65–68
   PubMed Web of Science ®Google Scholar
• Cochran E., Bacci B., Chen Y., Patton A., Gambetti P., Autilio-Gambetti L. Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease. American Journal of Pathology 1991; 139: 485–489
   Google Scholar
• Cork L.C., Masters C., Beyreuther K., Price D.L. Development of senile plaques—relationships of neuronal abnormalities and amyloid deposits. American Journal of Pathology 1990; 137: 1383–1392
   Google Scholar
• Cork L.C. Plaques in prefrontal cortex of aged, behaviourally-tested rhesus monkeys: Incidence, distribution, and relationship to task performance. Neurobiology of Aging 1993; 14: 675–676
   Google Scholar
• Cummings J.L., Victoroff J.I. Noncognitive neuropsychiatric syndromes in Alzheimer's disease. Neuropsychiatry, Neuropsychology and Behavioral Neurology 1990; 3: 140–158
   Google Scholar
• Davies C.L., Mann D.M.A., Sumpter P.Q., Yates P.O. A quantitative analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. Journal of Neurological Science 1987; 78: 151–164
   PubMed Web of Science ®Google Scholar
• Dayan A.D. Quantitative histological studies on die aged human brain. I. Senile plaques and neurofibrillary tangles in “normal” patients. Acta Neuropathologica (Berl) 1970; 16: 85–94
   PubMed Web of Science ®Google Scholar
• De Kosky S.T., Scheff S.W. Synaptic loss in frontal cortex biopsies in Alzheimer's disease. Correlation with cognitive severity. Annals of Neurology 1990; 27: 457–464
   Google Scholar
• De Toledo-Morrell L., Geinisman Y., Morrell F. Age-dependent alterations in hippocampal synaptic plasticity: Relation to memory disorders. Neurobiology of Aging 1988; 9: 581–590
   Google Scholar
• DeCarli C., Atack J.R., Ball M.J., Kay J.A., Grady C.L., Fewster P., Pettigrew K.D., Rapoport S.I., Schapiro M.B. Postmortem regional neurofibrillary tangle densities but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Azlheimer's disease patients. Neurodegeneration 1992; 1: 113–121
   Google Scholar
• Delaere P., He Y., Fayet G., Duyckaerts C., Hauw J.-J. βA4 deposits are constant in die brain of the oldest old: An immunocytochemical study of 20 French centenarians. Neurobiology of Aging 1993; 14: 191–194
   PubMedGoogle Scholar
• Dickson D.W., Wertkin A., Kress Y., Ksiezak-Reding H., Yen S.-H. Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Laboratory Investigations 1990; 63: 87–99
   Google Scholar
• Dickson D.W., Crystal H.A., Bevona C., Honer W., Vincent I., Davies P. Correlations of synaptic and padiological markers with cognition of the elderly. Neurobiology of Aging 1995; 16: 285–302
   PubMed Web of Science ®Google Scholar
• Dudek S.M., Johnson G.V.W. Transglutaminase facilitates the formation of polymers of die beta-amyloid peptide. Brain Research 1994; 651: 129–133
   PubMed Web of Science ®Google Scholar
• Englund E., Brun A., Alling C. White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. Brain 1988; 111: 1425–1439
   PubMed Web of Science ®Google Scholar
• Flood D.G., Coleman P.D. Failed compensatory dendritic growth as a pathophysiological process in Alzheimer's disease. Canadian Journal of Neurological Science 1986; 13: 475–479
   PubMedGoogle Scholar
• Freund G., Ballinger W.E. Loss of synaptic receptors can precede morphologic changes induced by alcoholism. Alcohol, & Alcoholism Supplement 1991; 1: 385–391
   Google Scholar
• Frisoni G.B., Govoni S., Geroldi C., Bianchetti A., Calabresi L., Franceschini G., Trabucchi M. Gene dose of the ε4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Annals of Neurology 1995; 37: 596–604
   PubMed Web of Science ®Google Scholar
• Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Giodo T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowttz P., Lieberburg I., Littele S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V7 17F, β-amyloid precursor protein. Nature 1995; 373: 523–527
   PubMed Web of Science ®Google Scholar
• Giannakopoulos P., Hof P.R., Surini M., Michel J.P., Bouras C. Quantitative immunochemical analysis of the distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of nonagenarians and centenarians. Acta Neuropathologica (Berl) 1993; 85: 602–610
   Google Scholar
• Giannakopoulos P., Hof P.R., Mottier S., Michel J.P., Bouras S. Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: Retrospective clinicopathological evaluation of a 10-year autopsy population. Acta Neuropathologica (Berl) 1994; 87: 456–468
   PubMed Web of Science ®Google Scholar
• Gibson P.H. Form and distribution of senile plaques seen in silver impregnated sections in the brains of intellectually normal elderly people and people with Alzheimer-type dementia. Neuropathology and Applied Neurobiology 1983; 9: 379–389
   Google Scholar
• Giovannelli L., Casamenti F., Scali C., Bartolini L., Pepeu G. Differential effects of amyloid peptides β-(1–40) and β-(25–35) injections into the rat nucleus basalis. Neuroscience 1995; 66: 781–792
   Google Scholar
• Gonatas N.K., Anderson W., Evangelista I. The contribution of altered synapses in the senile plaque: An electron microscopic study in Alzheimer's dementia. Journal of Neuropathological and Experimental Neurology 1967; 26: 25–39
   Google Scholar
• Grady C.L., Haxby J.V., Schlageter N.L., Berg G., Rapoport S.I. Stability of metabolic and neuropsychological assymetries in dementia of the Alzheimer's type. Neurology 1986; 36: 1390–1392
   PubMed Web of Science ®Google Scholar
• Greenberg S.M., Rebeck G.W., Vonsattel J.P.G., Gomez-Isla T., Hyman B.T. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Annals of Neurology 1995; 38: 254–259
   PubMed Web of Science ®Google Scholar
• Harrington C.R., Edwards P.C., Wischik C.M. Competitive ELISA for the measurement of tau protein in Alzheimer's disease. Journal of Immunological Methods 1990; 134: 261–271
   Google Scholar
• Harrington C.R., Mukaetova-Ladinska E.B., Hells R., Edwards P.C., Montejo de Garcini E., Novak M., Wischik C.M. Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1991; 88: 5842–5846
   Google Scholar
• Harrington C.R., Perry R.H., Perry E.K., Hurt J., McKeith I.G., Roth M., Wischik C.M. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia 1994; 5: 215–228
   PubMedGoogle Scholar
• Heinonen O., Soininen H., Syrjanen S., Neittaanmaki H., Paljarvi L., Kosunen O., Syrjanen K., Riekkinen P., Sr. β-Amyloid protein immunoreactivity in skin is not reliable marker of Alzheimer's disease. An autopsy-controlled study. Archives of Neurology 1994; 51: 799–804
   Google Scholar
• Heinonen O., Soininen H., Sorvari H., Kosunen O., Paljarvi L., Koivisto E., Riekkinen O. J., Sr. Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neuroscience 1995a; 64: 375–384
   PubMedGoogle Scholar
• Heinonen O., Lehtovirta M., Soininen H., Heulisalmi S., Mannermaa A., Sorvari H., Kosunen O., Paljarvi L., Ryynanen M., Riekkinen P. J., Sr. Alzheimer pathology of patients carrying apolipoprotein E ε4 allele. Neurobiology of Aging 1995b; 16: 505–513
   Google Scholar
• Helkala E.-L., Koivisto K., Hanninen T., Vanhanen M., Kervinen K., Kuusisto J., Mykkanen L., Kesaniemi Y.A., Laakso M., Riekkinen P., Sr. The association of apolipoprotein E polymorphism with memory: A population based study. Neuroscience Letters 1995; 191: 141–144
   PubMed Web of Science ®Google Scholar
• Henriksson T., Barbour R.M., Braa S., Ward P., Fritz L.C., Johnson-Wood K., Chung H.D., Burke W., Reinikainen K.J., Kiekkinen P., Schenk D.B. Analysis and quantitation of the β-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay. Journal of Neurochemistry 1991; 56: 1037–1042
   PubMed Web of Science ®Google Scholar
• Higgins L.S., Holtzman D.M., Rabin J., Mobley W.C., Cordell B. Transgenic mouse brain histopathology resembles early Alzheimer's disease. Annals of Neurology 1994; 35: 598–607
   PubMed Web of Science ®Google Scholar
• Higgins L.S., Rodems J.M., Catalano R., Quon D., Cordell B. Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for β-APP751. Proceedings of the National Academy of Sciences, USA 1995; 92: 4402–4406
   PubMed Web of Science ®Google Scholar
• Ho G.J., Gregory E.J., Smirnova I.V., Zoubine M.N., Festoff B.W. Cross-linking of β-amyloid protein precursor catalyzed by tissue transglutaminase. FEBS Letters 1994; 349: 151–154
   Google Scholar
• Hock C., Golombowski S., Naser W., Muller-Spahn F. Increased levels of τ protein in cerebrospinal fluid of patients with Alzheimer's disease—correlation with degree of cognitive impairment. Annals of Neurology 1995; 37: 414–415
   Google Scholar
• Hof P.R., Bouras C., Buee L., Delacourte A., Perl D.P., Morrison J.H. Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta Neuropathologica (Berl) 1992; 85: 23–30
   PubMed Web of Science ®Google Scholar
• Honer W., Kaufmann C., Daves P. Characterization of a synaptic antigen of interest in neuropsychiatric illness. Biological Psychiatry 1992; 31: 147–158
   PubMed Web of Science ®Google Scholar
• Howland D.S., Savage M.J., Huntress A., Wallace R.E., Schwartz D.A., Loh T., Melloni R. H., Jr, Degennaro L.J., Greenberg B.D., Siman R., Swanson M.E., Scott R.W. Mutant and native human β-amyloid precursor proteins in transgenic mouse brain. Neurobiology of Aging 1995; 16: 685–699
   PubMed Web of Science ®Google Scholar
• Hubbard B.M., Fenton G.W., Anderson J.M. A quantitative histological study of early and preclinical Alzheimer's disease. Neuropathology and Applied Neurobiology 1990; 16: 111–121
   PubMed Web of Science ®Google Scholar
• Huppert F.A., Kopelman M.D. Rates of forgetting in normal ageing: A comparison with dementia. Neuropsychology 1989; 27: 849–860
   Google Scholar
• Hyman B.T., West H.L., Rebeck G.W., Lai F., Mann D.M.A. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Archives of Neurology 1995; 52: 373–378
   PubMedGoogle Scholar
• Ihara Y. What mediates between β-amyloid and PHF. Neurobiology of Aging 1989; 10: 573–574
   Google Scholar
• Ikura K., Takahata K., Sasaki R. Cross-linking of a synthetic partial-length (1–28) peptide of the Alzheimer β/A4 amyloid protein by transglutaminase. FEBS Utters 1993; 326: 109–111
   PubMed Web of Science ®Google Scholar
• Jensen M., Basun H., Lannfelt L. Increased cerebrospinal fluid tau in patients with Alzheimer's disease. Neuroscience Letters 1995a; 186: 189–191
   PubMed Web of Science ®Google Scholar
• Jensen P.H., Sorensen E.S., Petersen T.E., Gliemann J., Rasmussen L.K. Residues in the synuclein consensus motif of the α-synuclein fragment, NAC, precipitate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid βA4. Biochemical Journal 1995b; 310: 91–94
   PubMedGoogle Scholar
• Khachaturian Z.S. Status of Alzheimer's disease research. Alzheimer's disease: Problems, Prospects and Prospectives, J.H. Altman. Plenum Press, New York, London 1987; 183–189
   Google Scholar
• Kitaguchi N., Tokushima Y., Oishi K., Takahashi Y., Shiojiri S., Nakamura S., Tanaka S., Kodaira R., Ito H. Determination of amyloid β protein precursors harbouring active form of proteinase inhibitor domains in cerebrospinal fluid of Alzheimer's disease patients by trypsin-anti-body sandwich ELISA. Biochemical and Biophysical Research Communications 1990; 166: 1453–1459
   Google Scholar
• Lai R.Y.K., Gertz H. N-J., Wischik D.J., Xuereb J.H., Mukaetova-Ladinska E.B., Harrington C.R., Edwards P.C., Mena R., Paykel E.S., Brayne C., Huppert F.A., Roth M., Wischik C.M. Examination of phosphorylated tau protein as a PHF-precursor at early stage Alzheimer's disease. Neurobiology of Aging 1995; 16: 433–445
   Google Scholar
• Langui D., Probst A., Ulrich J. Alzheimer's changes in non-demented and demented patients: A statistical approach to their relationship. Acta Neuropathologica (Berl) 1995; 89: 57–62
   Google Scholar
• Lippa C.F., Hamos J.E., Pulaski-Salo D., DeGennaro L.J., Drachman D.A. Alzheimer's disease and aging: Effects on perforant pathway perikarya and synapses. Neurobiology of Aging 1992; 13: 405–411
   Google Scholar
• Lishman W.A. Organic Psychiatry. The Psychological Consequences of Cerebral Disorder. Blackwell Scientific Publications, Oxford 1987
   Google Scholar
• Mann D.M.A., Tucker C.M., Yates P.O. The topographic distribution of senile plaques and neurofibrillary tangles in the brains of non-demented persons of different ages. Neuropathology and Applied Neurobiology 1987; 13: 123–139
   PubMed Web of Science ®Google Scholar
• Mann D.M.A., Marcyniuk B., Yates P.O., Neary D., Snowden J.S. The progression of the pathological changes in Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and autopsy. Neuropathology and Applied Neurobiology 1988; 14: 177–195
   PubMed Web of Science ®Google Scholar
• Mann D.M.A. The pathogenesis and progression of the pathological changes of Alzheimer's disease. Alzheimer's Disease, D.C. Davies. John Wiley, & Co Ltd, London 1989; 43–53
   Google Scholar
• Masliah E., Terry R.D., Mallory M., Alford M., Hansen L.A. Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. American Journal of Pathology 1990; 137: 1293–1297
   PubMed Web of Science ®Google Scholar
• Masliah E., Terry R.D., Alford D., DeTeresa R., Hansen L.A. Cortical and subcortical patterns of synaptophysin immunoreactiviry in Alzheimer's disease. American Journal of Pathology 1991; 138: 235–246
   PubMed Web of Science ®Google Scholar
• Masliah E., Mallory M., Hansen L., DeTeresa R., Terry R. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 1993a; 43: 192–197
   PubMed Web of Science ®Google Scholar
• Masliah E., Mallory M., Deerinck T., DeTeresa R., Lamont S., Miller A., Terry R.D., Carragher B., Ellisman M. Reevaluation of the structural organization of neuritic plaques in Alzheimer's disease. Journal of Neuropathological and Experimental Neurology 1993b; 52: 619–632
   PubMed Web of Science ®Google Scholar
• Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proceedings of the National Academy of Science, USA 1985; 8: 4245–4249
   Google Scholar
• McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944
   PubMed Web of Science ®Google Scholar
• Mena R., Wischik C.M., Novak M., Milstein C., Cuello A.C. A progressive deposition of paired helical filaments (PHF) in the brain characterizes the evolution of dementia in Alzheimer's disease. An immunohistochemical study with a monoclonal antibody against die PHF core. Journal of Neuropathological and Experimental Neurology 1991; 50: 474–490
   Google Scholar
• Migheli A., Attanasio A., Perrulo T., Gullotta F., Giordana M.T., Schiffer D. Age-related ubiquitin deposits in dystrophic neurites: Immunoelectron microscopic study. Neuropathology and Applied Neurobiology 1992; 18: 3–11
   PubMed Web of Science ®Google Scholar
• Mori H., Hosoda K., Matsubara E., Nakamoto T., Furiya Y., Endoh R., Usami M., Shoji M., Maruyama S., Hirai S. Tau in cerebrospinal fluids: Establishment of die sandwich ELISA with antibody specific to the repeat sequence in tau. Neuroscience Letters 1995; 186: 181–183
   PubMed Web of Science ®Google Scholar
• Morimatsu M., Hirai S., Muzamatsu A., Yoshikawa M. Senile degenerative brain lesions and dementia. Journal of the American Geriatric Society 1975; 23: 390–406
   PubMedGoogle Scholar
• Morris J.C., McKeel D. W., Jr, Fulling K., Torack R.M., Nerg L. Validation of clinical diagnostic criteria for Alzheimer's disease. Annals of Neurology 1988; 24: 17–22
   PubMed Web of Science ®Google Scholar
• Mucke L., Masliah E., Johnson W.B., Ruppe M.D., Alford M., Rockenstein E.M., Forss-Petter S., Pietropaolo M., Mallory M., Abraham C.R. Synaptotrophic effects of human amyloid protein precursors in the cortex of transgenic mice. Brain Research 1994; 666: 151–167
   PubMed Web of Science ®Google Scholar
• Mukaetova-Ladinska E.B., Harrington C.R., Hills R., O'Sullivan A., Roth M., Wischik C.M. Regional distribution of paired helical filaments and normal tau proteins in aging and in Azlheimer's disease with and without occipital lobe involvement. Dementia 1992; 3: 61–69
   Google Scholar
• Mukaetova-Ladinska E.B., Harrington C.R., Roth M., Wischik C.M. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease. American Journal of Pathology 1993; 143: 565–578
   PubMed Web of Science ®Google Scholar
• Mukaetova-Ladinska E.B., Harrington C.R., Roth M., Wischik C.M. Distribution of tau protein in Down's syndrome: Quantitative differences from Alzheimer's disease. Developmental Brain Dysfunction 1994; 7: 311–329
   Google Scholar
• Mukaetova-Ladinska E.B., Harrington C.R., Xuereb J., Roth M., Wischik C.M. Biochemical, neuropadiological, and clinical correlations of neurofibrillary degeneration in Alzheimer's disease. Treating Alzheimer's and Other Dementias. Clinical Application of Recent Research Advances, M. Bergener, S.I. Finkel. Springer Publishing Company, New York 1995; 57–80
   Google Scholar
• Mukaetova-Ladinska E.B., Harrington C.R., Roth M., Wischik C.M. Alterations in tau protein metabolism during normal aging. Dementia.
   Google Scholar
• Murphy G.M., Eng L.F., Ellis W.G., Perry G., Meissner L.C., Tinklenberg J.R. Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: A comparison with Alzheimer's disease. Brain Research 1990; 537: 102–108
   Google Scholar
• Nagy Zs., Esiri M.M., Jobst K.A., Morris J.H., King E. M.-F., McDonald B., Litchfield S., Smith A., Barnetson L., Smith A.D. Relative roles of plaques and tangles in die dementia of Alzheimer's diesease: Correlations using three sets of neuropathological criteria. Dementia 1995; 6: 21–31
   PubMedGoogle Scholar
• Nakamura T., Shoji M., Harigaya Y., Watanabe M., Hosoda K., Cheung T.T., Shaffer L.M., Golde T.E., Younkin L.H., Younkin S.G., Hirai S. Amyloid β protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease. Annals of Neurology 1994; 36: 903–911
   Google Scholar
• Neary D., Snowden J.S., Mann D.M.A., Bowen D.M., Sims N.R., Northen B., Yates P.O., Davison A.N. Alzheimer's disease: A correlative study. Journal of Neurology, Neurosurgery and Psychiatry 1986; 49: 229–237
   PubMed Web of Science ®Google Scholar
• Nitta A., Itoh A., Hasegawa T., Nabeshima T. β-amyloid protein-induced Alzheimer's disease animal model. Neuroscience Letters 1994; 170: 63–66
   PubMed Web of Science ®Google Scholar
• Palmert M.R., Usiak M., Mayeux R., Raskind M., Tourtellotte W.W., Younkin S.G. Soluble derivatives of the β amyloid protein precursor in cerebrospinal fluid: Alterations in normal aging and in Alzheimer's disease. Neurology 1990; 40: 1028–1034
   PubMedGoogle Scholar
• Paykel E.S., Brayne C., Huppert F.A., Gill C., Barkley C., Gehlhaar E., Beardsall L., Girling D., Pollitt P., O'Connor D. Incidence of dementia in a population older than 75 years in the United Kingdom. Archives of General Psychiatry 1994; 51: 325–332
   PubMedGoogle Scholar
• Pearson R.C.A., Powell T.P.S. The neuroanatomy of Alzheimer's disease. Reviews in Neuroscience 1989; 2: 101–122
   PubMedGoogle Scholar
• Podlisny M.B., Stephenoson D.T., Frosch M.P., Lieberburg I., Clemens J.A., Selkoe D.J. Synthetic amyloid β-protein fails to produce specific neurotoxicity in monkey cerebral cortex. Neurobiology of Aging 1992; 13: 561–568
   PubMed Web of Science ®Google Scholar
• Prior R., Monning U., Schreiter-Gasser U., Weidemann A., Blennow K., Gotffries C.G., Masters C.L., Beyreuther K. Quantitative changes in die amyloid βA4 precursor protein in Alzheimer cerebrospinal fluid. Neuroscience Letters 1991; 124: 69–73
   PubMedGoogle Scholar
• Rasmussen L.K., Sorensen E.S., Peterson T.E., Guemann J., Jensen P.H. Identification of glutamine and lysine residues in Alzheimer amyloid βA4 peptide responsible for transglutaminase-catalysed homopolymerization and cross-linking to α2M receptor. FEBS Letters 1994; 338: 161–166
   PubMed Web of Science ®Google Scholar
• Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease. Neuron 1993; 11: 575–580
   PubMed Web of Science ®Google Scholar
• Reed T., Carmelli D., Swan G.E., Breitner J.C.S., Welsh K.A., Jarvik G.P., Deeb S., Auwerx J. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele. Archives of Neurology 1994; 51: 1189–1192
   PubMedGoogle Scholar
• Regland B., Gotffries C.-G. The role of amyloid β-protein in Alzheimer's disease. Lancet 1992; 340: 467–469
   PubMed Web of Science ®Google Scholar
• Richards S.-J., Waters J.J., Beyreuther K., Masters C.L., Wischik C.M., Sparkman D.R., White C. L., III, Abraham C.R., Dunnett S.B. Transplants of mouse trisomy 16 hippocampus provide a model of Alzheimer's disease neuropathology. EMBO Journal 1991; 10: 297–303
   Google Scholar
• Ritchie K. Mental status examination of an exceptional case of longevity JC aged 118 years. British Journal of Psychiatry 1995; 166: 229–235
   PubMed Web of Science ®Google Scholar
• Roth M., Tomlinson B.E., Blessed G. Correlation between scores for dementia and counts of ‘senile plaques’ in cerebral grey matter of elderly subjects. Nature 1966; 209: 109–110
   PubMedGoogle Scholar
• Roth M., Tym E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., Goddard R. CAMDEX: A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry 1986; 149: 698–709
   PubMed Web of Science ®Google Scholar
• Rothschield D. Pathologic changes in senile psychosis and their pathobiologic significance. American Journal of Psychaitry 1937; 93: 757–784
   Google Scholar
• Rumble B., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., Hockey A., Montgomery P., Beyreuther K., Masters C.L. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. New England Journal of Medicine 1989; 320: 1446–1452
   PubMed Web of Science ®Google Scholar
• Schmidt R.E., Chae H.Y., Paryn C.A., Roth K.A. Neuroaxonal dystrophy in aging human sympathetic ganglia. American Journal of Pathology 1990; 136: 1327–1338
   Google Scholar
• Scoville W.B., Milner B. Loss of recent memory after bilateral hippocampal lesions. Journal of Neurology, Neurosurgery and Psychiatry 1957; 20: 11–21
   PubMed Web of Science ®Google Scholar
• Shin R.-W., Bramblett G., Lee V. M.-Y., Trojanowski J.Q. Alzheimer disease A68 proteins injected into rat brain induce codeposits of β-amyloid, ubiquitin and a α1-antichymotrypsin. Proceedings of the National Academy of Science, USA 1993; 90: 6825–6828
   PubMed Web of Science ®Google Scholar
• Simchowisc T. Histologische Srudien uber die senile demenz. Histologie und histopathologische Arbeiten uber die grobhimrinde, F. Hrsg, A. Nissle. Alzheimer, Jena 1911; 267–444
   Google Scholar
• Smyth M.D., Kesslak J.P., Cummings B.J., Cotman C.W. Analysis of brain injury following intrahippocampal administration of β-amyloid in streptozotocin-treated rats. Neurobiology of Aging 1994; 15: 153–159
   Google Scholar
• Snowdon J., Lane F. A longitudinal study of age-associated memory impairment. International Journal of Geriatric Psychiatry 1994; 9: 779–787
   Google Scholar
• Soininen H., Syrjami S., Heinonen O., Neittaanmaki H., Miettinen R., Paljarvi L., Syrjanen K., Beyreuther K., Riekkinen P. Amyloid β-protein deposition in skin of patients with dementia. Lancet 1992; 339: 245
   Google Scholar
• Stephenson D.T., Podlisny M.B., Games D., Lieberburg I., Selkoe D.J., Clemens J.A. Effects of implants of β-amyloid protein in monkey cerebral cortex. Neurodegeneration 1992; 1: 177–187
   Google Scholar
• Stoll J., Balbo A., Ault B., Rapoport S.I., Fine A. Long-term transplants of mouse trisomy 16 hippocampal neurons, a model for Down's syndrome, do not develop Alzheimer's disease neuropathology. Brain Research 1993; 610: 295–304
   Google Scholar
• Sugihara S., Ogawa A., Nakazato Y., Yamaguchi H. Cerebral, β-amyloid deposition in patients with malignant neoplasms: Its prevalence with aging and effects of radiation therapy on vascular amyloid. Acta Neuropathologica (Berl) 1995; 90: 135–141
   PubMed Web of Science ®Google Scholar
• Sullivan E.V., Marsh L., Mathalon D.H., Lim K.O., Pfefferbaum A. Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiology of Aging 1995; 16: 591–606
   PubMed Web of Science ®Google Scholar
• Tabaton M., Nunzi M.G., Usiak M., Autillio-Gambetti L., Gambetti P. Soluble β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochemical and Biophysical Research Communication 1994; 200: 1598–1603
   PubMed Web of Science ®Google Scholar
• Teri L., Larson E.B., Reifler B.V. Behavioural disturbance in dementia of the Alzheimer type. Journal of the American Geriatric Society 1988; 36: 1–6
   PubMed Web of Science ®Google Scholar
• Terry R.D., Masliah E., Salmon D., Butters N., DeTeresa R., Hill R., Hansen L., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Annals of Neurology 1991; 30: 572–580
   PubMed Web of Science ®Google Scholar
• Teunisse S., Derix M.M.A., van Crevel H. Assessing the severity of dementia. Patient and caregiver. Archives of Neurology 1991; 48: 274–277
   PubMed Web of Science ®Google Scholar
• Tomlinson B.E., Blessed G., Roth M. Observations on the brains of non-demented old people. Journal of Neurological Science 1968; 7: 331–356
   PubMed Web of Science ®Google Scholar
• Tym E.L. Diagnostic assessment in dementia. Dementia Disorders, C.L.E. Katona. Chapman and Hall, London, New York 1990; 18–43
   Google Scholar
• Ueda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D.A.C., Kondo J., Ihara Y., Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1993; 90: 11282–11286
   PubMed Web of Science ®Google Scholar
• Ulrich J., Spillantini M.G., Goedert M., Dukas L., Stahelin H.B. Abundant neurofibrillary tangles without senile-plaques in a subset of patients with senile dementia. Neurodegeneration 1992; 1: 257–264
   Google Scholar
• Van Nostrand W.E., Wagner S.L., Shankle W.R., Farrow J.S., Dick M., Rozemuller J.M., Kuiper M.A., Wolters E.C., Zimmerman J., Cotman C.W., Cunningham D.D. Decreased levels of soluble amyloid β-protein precursor in cerebrospinal fluid of live Alzheimer disease patients. Proceedings of the National Academy of Science, USA 1992; 89: 2551–2555
   PubMed Web of Science ®Google Scholar
• van der Bliek A.M., Meyerowttz E.M. Dynamin-like protein encoded by the Drosophila shibire gene associated with vesicular traffic. Nature 1991; 351: 411–414
   PubMed Web of Science ®Google Scholar
• Van Gool W.A., Kuiper M.A., Walstra G.J.M., Wolters E. Ch., Bolhuis P.A. Concentrations of amyloid β protein in cerebrospinal fluid of patients with Alzheimer's disease. Annals of Neurology 1995; 37: 277–279
   Google Scholar
• Vandermeeren M., Mercken M., Vanmechelen E., Six J., van de Voorde A., Martin J.J., Cras P. Detection of tau protein in normal, and Alzheimer's disease cererospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. Journal of Neurochemistry 1993; 61: 1828–1834
   PubMed Web of Science ®Google Scholar
• Victor M., Angevime J.B., Mancall E.L., Fisher C.M. Memory loss with lesions of hippocampal formation. Archives of Neurology 1961; 5: 244–263
   PubMedGoogle Scholar
• Vigo-Pelfrey C., Seubert P., Barbour R., Blomquist C., Lee M., Lee D., Coria F., Chang L., Miller B., Lieberburg I., Schenk D. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology 1995; 45: 788–793
   PubMed Web of Science ®Google Scholar
• Wagner S.L., Peskind E.R., Nochlin D., Provow S., Farrow J.S., Pandian M.R., Cleveland M., Ito R.K., Farlow M.R. Decreased levels of soluble amyloid β-protein precursor are associated with Alzheimer's disease in concordant and discordant monozygous twin pairs. Annals of Neurology 1994; 36: 215–220
   Google Scholar
• Wang D., Munoz D.G. Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer's disease and normal aged brain. Journal of Neuropathology and Experimental Neurology 1995; 54: 548–556
   Google Scholar
• Wilcock G., Esiri M.M. Plaques, tangles and dementia. Quantitative study. Journal of Neurological Science 1982; 56: 343–356
   PubMed Web of Science ®Google Scholar
• Wischik C.M., Novak M., Thogersen H.C., Edwards P.C., Runswick M.J., Jakes R., Walker J.E., Milstein C., Roth M., Klug A. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1988; 85: 4506–4510
   PubMed Web of Science ®Google Scholar
• Wolozin B., Davies P. Alzheimer-related neuronal protein A68: Specificity and distribution. Annals of Neurology 1987; 22: 521–526
   PubMedGoogle Scholar
• Wood R.A. Memory loss. British Medical Journal 1984; 288: 1443–1447
   Google Scholar
• Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β-protein: Reversal by tachykinin neuropeptides. Science 1990; 250: 279–282
   PubMed Web of Science ®Google Scholar
• Zhan S.S., Beyreuther K., Schmitt H.P. Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with the dementia of Alzheimer type and nondemented controls. Dementia 1993; 5: 79–87
   Google Scholar